Bank of Nova Scotia’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,355
Closed -$67.1K 1022
2025
Q1
$67.1K Buy
10,355
+52
+0.5% +$374 ﹤0.01% 981
2024
Q4
$83.3K Buy
+10,303
New +$84.9K ﹤0.01% 991
2023
Q4
Sell
-21,162
Closed -$175K 1010
2023
Q3
$175K Buy
21,162
+536
+3% +$4.62K ﹤0.01% 958
2023
Q2
$165K Buy
+20,626
New +$152K ﹤0.01% 984
2022
Q4
Sell
-385,339
Closed -$2.66M 1171
2022
Q3
$2.66M Sell
385,339
-1,926,207
-83% -$13.4M 0.01% 570
2022
Q2
$19.4M Sell
2,311,546
-4,398
-0.2% -$61.5K 0.05% 278
2022
Q1
$52.9M Buy
2,315,944
+2,645
+0.1% +$64.7K 0.09% 184
2021
Q4
$63.9M Sell
2,313,299
-336
-0% -$8.99K 0.09% 207
2021
Q3
$64.5M Sell
2,313,635
-142,271
-6% -$4.03M 0.11% 171
2021
Q2
$72.1M Sell
2,455,906
-8,190
-0.3% -$248K 0.13% 143
2021
Q1
$78.2M Buy
2,464,096
+13,134
+0.5% +$385K 0.15% 131
2020
Q4
$51M Buy
2,450,962
+6,518
+0.3% +$122K 0.11% 171
2020
Q3
$38M Buy
+2,444,444
New +$42.1M 0.1% 174
2020
Q2
Sell
-2,626,530
Closed -$40.7M 945
2020
Q1
$40.7M Buy
2,626,530
+5,848
+0.2% +$141K 0.14% 141
2019
Q4
$78.4M Buy
2,620,682
+336,130
+15% +$8.74M 0.19% 121
2019
Q3
$49.9M Buy
2,284,552
+944,220
+70% +$21.6M 0.15% 139
2019
Q2
$32M Buy
1,340,332
+44,362
+3% +$1.05M 0.13% 153
2019
Q1
$32M Buy
1,295,970
+88,823
+7% +$2.12M 0.13% 166
2018
Q4
$22.3M Buy
1,207,147
+154,143
+15% +$3.67M 0.1% 176
2018
Q3
$27.1M Buy
1,053,004
+52,743
+5% +$1.21M 0.12% 164
2018
Q2
$23.2M Buy
1,000,261
+59,783
+6% +$1.24M 0.13% 139
2018
Q1
$15M Sell
940,478
-540,157
-36% -$10.1M 0.08% 228
2017
Q4
$30.8M Buy
1,480,635
+528,900
+56% +$8.39M 0.14% 148
2017
Q3
$13.6M Sell
951,735
-223,329
-19% -$3.38M 0.08% 209
2017
Q2
$20.4M Sell
1,175,064
-85,954
-7% -$1.03M 0.11% 174
2017
Q1
$13.9M Buy
1,261,018
+596,341
+90% +$8.2M 0.06% 236
2016
Q4
$9.55M Buy
664,677
+66,657
+11% +$1.22M 0.05% 200
2016
Q3
$14.7M Sell
598,020
-222,347
-27% -$5.75M 0.08% 125
2016
Q2
$16.5M Buy
820,367
+223,326
+37% +$6.32M 0.1% 114
2016
Q1
$15.7M Sell
597,041
-247,000
-29% -$18.3M 0.1% 115
2015
Q4
$85.7M Sell
844,041
-173,258
-17% -$19.5M 0.44% 45
2015
Q3
$182M Sell
1,017,299
-295,521
-23% -$68.9M 0.98% 19
2015
Q2
$291M Sell
1,312,820
-116,579
-8% -$25.8M 1.45% 14
2015
Q1
$282M Buy
1,429,399
+2,694
+0.2% +$478K 1.26% 17
2014
Q4
$204M Sell
1,426,705
-57,263
-4% -$7.7M 0.78% 24
2014
Q3
$194M Buy
1,483,968
+229,110
+18% +$27.3M 0.79% 25
2014
Q2
$159M Sell
1,254,858
-9,000
-0.7% -$1.15M 0.65% 25
2014
Q1
$166M Sell
1,263,858
-12,900
-1% -$1.76M 0.69% 23
2013
Q4
$150M Buy
1,276,758
+64,600
+5% +$7.08M 0.63% 24
2013
Q3
$126M Buy
1,212,158
+36,296
+3% +$3.54M 0.64% 20
2013
Q2
$101M Buy
+1,175,862
New +$92.7M 0.52% 28

Other funds holding BHC

Bank of Nova Scotia's BHC Position: Q2 2025 in Review

Bank of Nova Scotia sold out of Bausch Health (BHC) in Q2 2025, closing a stake of 10,355 shares — an estimated $67.1K sold.

Bank of Nova Scotia first reported a position in BHC in Q2 2013 and held it in 41 quarters. The position peaked at $291M in Q2 2015. 212 funds tracked by Wall St. Rank hold BHC as of Q2 2025.

  • Bank of Nova Scotia reported no remaining Bausch Health position as of Q2 2025 after selling out during the quarter.
  • Bank of Nova Scotia sold 10,355 Bausch Health shares in Q2 2025, an estimated $67.1K.
  • Bank of Nova Scotia first reported a position in Bausch Health in Q2 2013 and held it in 41 quarters.
  • Bank of Nova Scotia's Bausch Health position peaked at $291M in Q2 2015.
  • 212 funds tracked by Wall St. Rank held Bausch Health as of Q2 2025.

Based on Bank of Nova Scotia's 13F filing for Q2 2025, filed 13 Aug 2025.